Cargando…
Metformin as a Therapeutic Target in Endometrial Cancers
Endometrial cancer is the most common gynecologic malignancy in developed countries. Its increasing incidence is thought to be related in part to the rise of metabolic syndrome, which has been shown to be a risk factor for the development of hyperestrogenic and hyperinsulinemic states. This has cons...
Autores principales: | Lee, Teresa Y., Martinez-Outschoorn, Ubaldo E., Schilder, Russell J., Kim, Christine H., Richard, Scott D., Rosenblum, Norman G., Johnson, Jennifer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121131/ https://www.ncbi.nlm.nih.gov/pubmed/30211120 http://dx.doi.org/10.3389/fonc.2018.00341 |
Ejemplares similares
-
Metabolic Pathways and Targets in Chondrosarcoma
por: Micaily, Ida, et al.
Publicado: (2021) -
Metformin Clinical Trial in HPV+ and HPV– Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate
por: Curry, Joseph M., et al.
Publicado: (2018) -
Autophagy Machinery as a Promising Therapeutic Target in Endometrial Cancer
por: Nuñez-Olvera, Stephanie I., et al.
Publicado: (2019) -
The Hippo pathway in endometrial cancer: a potential therapeutic target?
por: Shen, Xinyun, et al.
Publicado: (2023) -
Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer
por: Eldredge-Hindy, Harriet Belding, et al.
Publicado: (2014)